Kannan Sridharan
Kannan Sridharan is an expert in Pharmacy at Arabian Gulf University (Bahrain). As of October 2026, ScienceLeadR ranks Kannan Sridharan in the top 1% of experts worldwide for Artificial Intelligence and Meta-Analysis as Topic, and in the top 1% of experts in Bahrain for Machine Learning. Kannan Sridharan has authored 283 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,186 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Public Health - Pediatrics - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 283
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Global Burden of Anorexia Nervosa and Bulimia Nervosa, 1990 to 2023, With Forecasts to 2050: A Global Burden of Disease Study 2023 Analysis. PMID 42949727 — bulimia nervosa, anorexia, mortality, bulimia, mental disorders, global burden of disease, prevalence, cost of illness, anorexia nervosa, mental health | JAMA Psychiatry | 2026 | 0 |
| Global, regional, and national burden of unintentional poisoning, 1990-2023: results from the Global Burden of Disease Study 2023. PMID 42945982 — incidence, poisoning, public health, uncertainty, pesticides, global burden of disease, cost of illness, demography | Lancet Public Health | 2026 | 0 |
| Drug-associated torsades de pointes and QT prolongation in infants: A focused real-world disproportionality analysis pharmacovigilance study. PMID 41896159 — tachycardia, ventricular, pharmaceutical preparations, drug-related side effects and adverse reactions, tachycardia, risk factors, pediatrics, torsades de pointes, pharmacovigilance, infant | Pediatr Neonatol | 2026 | 2 |
| Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. PMID 42385762 — fasting, mortality, tuberculosis, multidrug-resistant, incidence, global health, pharmaceutical preparations, global burden of disease, hiv, tuberculosis, risk factors, morbidity, cost of illness, smoking, communicable diseases, plasma | Lancet Infect Dis Top journal | 2026 | 2 |
| Congenital/Inherited CD59 Deficiency: A Systematic Review. PMID 42882210 — genes, complement membrane attack complex, anemia, hemolytic, phenotype, polyneuropathies, genotype, complement system proteins, therapeutics | J Clin Med | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map